Mostrar el registro sencillo del ítem

Artículo

dc.creatorMuñoz García, Rocíoes
dc.creatorSánchez Hidalgo, Marinaes
dc.creatorMontoya García, Tatianaes
dc.creatorAlcarranza Saucedo, Manueles
dc.creatorOrtega Vidal, Juanes
dc.creatorAltarejos, Joaquines
dc.creatorAlarcón de la Lastra Romero, Catalinaes
dc.date.accessioned2022-11-17T10:05:22Z
dc.date.available2022-11-17T10:05:22Z
dc.date.issued2022
dc.identifier.citationMuñoz García, R., Sánchez Hidalgo, M., Montoya García, T., Alcarranza Saucedo, M., Ortega Vidal, J., Altarejos, J. y Alarcón de la Lastra Romero, C. (2022). Effects of Oleacein, a New Epinutraceutical Bioproduct from Extra Virgin Olive Oil, in LPS-Activated Murine Immune Cells. Pharmaceuticals, 15 (11), 1338. https://doi.org/10.3390/ph15111338.
dc.identifier.issn1424-8247es
dc.identifier.urihttps://hdl.handle.net/11441/139545
dc.description.abstractThe present study was designed to evaluate the immunomodulatory effects of the secoiridoid from extra virgin olive oil, oleacein (OLA), deepening into the possible signaling pathways involved in LPS-activated murine peritoneal macrophages. Moreover, we have explored OLA-induced epigenetic changes in histone markers and related cytokine production in murine LPS-stimulated murine splenocytes. Murine cells were treated with OLA in the presence or absence of LPS (5 μg/mL) for 18 or 24 h. OLA modulated the oxidative stress and the inflammatory response produced by LPS stimulation in murine peritoneal macrophages, by the inhibition of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IFN-γ, IL-17 and IL-18) and ROS production and the expression of pro-inflammatory enzymes such as iNOS, COX-2 and m-PGES1. These protective effects could be due to the activation of the Nrf-2/HO-1 axis and the inhibition of JAK/STAT, ERK and P38 MAPKs and inflammasome canonical and non-canonical signaling pathways. Moreover, OLA modulated epigenetic modifications throughout histone methylation deacetylation (H3K18ac) and (H3K9me3 and H3K27me) in LPS-activated spleen cells. In conclusion, our data present OLA as an interesting anti-inflammatory and antioxidant natural compound that is able to regulate histone epigenetic markers. Nevertheless, additional in vivo studies are required to further investigate the beneficial effects of this EVOO secoiridoid, which might be a promising epinutraceutical bioproduct for the management of immune-related inflammatory diseases.es
dc.description.sponsorshipMINISTERIO DE ECONOMÍA Y COMPETITIVIDAD OF SPAIN, grant number AG-2017-89342-P and JUNTA DE ANDALUCÍA (CTS-259 and FQM-182)es
dc.formatapplication/pdfes
dc.format.extent20 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofPharmaceuticals, 15 (11), 1338.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectepigenetices
dc.subjecthistonees
dc.subjectinflammationes
dc.subjectimmunityes
dc.subjectmacrophageses
dc.subjectoleaceines
dc.subjectolive oiles
dc.subjectspleen cellses
dc.titleEffects of Oleacein, a New Epinutraceutical Bioproduct from Extra Virgin Olive Oil, in LPS-Activated Murine Immune Cellses
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacologíaes
dc.relation.projectIDAG-2017-89342-Pes
dc.relation.projectIDCTS-259es
dc.relation.projectIDFQM-182es
dc.relation.publisherversionhttps://dx.doi.org/10.3390/ph15111338es
dc.identifier.doi10.3390/ph15111338es
dc.journaltitlePharmaceuticalses
dc.publication.volumen15es
dc.publication.issue11es
dc.publication.initialPage1338es
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). Españaes
dc.contributor.funderJunta de Andalucíaes

FicherosTamañoFormatoVerDescripción
pharmaceuticals-15-01338.pdf3.374MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional